Agilon Health Inc (NYSE: AGL) is -83.67% lower on its value in year-to-date trading and has touched a low of $1.50 and a high of $13.76 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AGL stock was last observed hovering at around $2.26 in the last trading session, with the day’s loss setting it -0.21%.
Currently trading at $2.05, the stock is -3.82% and -27.56% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.58 million and changing -9.29% at the moment leaves the stock -58.49% off its SMA200. AGL registered -82.33% loss for a year compared to 6-month loss of -64.41%. The firm has a 50-day simple moving average (SMA 50) of $2.8618 and a 200-day simple moving average (SMA200) of $4.96575.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -24.07% gain in the last 1 month and extending the period to 3 months gives it a -51.07%, and is 28.93% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.44% over the week and 10.35% over the month.
Agilon Health Inc (AGL) has around 1117 employees, a market worth around $844.64M and $5.59B in sales. Profit margin for the company is -6.01%. Distance from 52-week low is 36.67% and -85.10% from its 52-week high. The company has generated returns on investments over the last 12 months (-54.31%).
with sales reaching $1.52B over the same period.The EPS is expected to shrink by -15.83% this year, but quarterly earnings will post 40.17% year-over-year. Quarterly sales are estimated to grow 43.85% in year-over-year returns.
Agilon Health Inc (AGL) Top Institutional Holders
294.0 institutions hold shares in Agilon Health Inc (AGL), with institutional investors hold 106.95% of the company’s shares. The shares outstanding are 406.39M, and float is at 303.27M with Short Float at 11.94%. Institutions hold 105.04% of the Float.
The top institutional shareholder in the company is CLAYTON, DUBILIER & RICE, LLC with over 100.0 million shares valued at $654.0 million. The investor’s holdings represent 24.3149% of the AGL Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 56.93 million shares valued at $372.3 million to account for 13.8418 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 56.41 million shares representing 13.7168% and valued at over $368.94 million, while WELLINGTON MANAGEMENT GROUP LLP holds 13.4653 of the shares totaling 55.38 million with a market value of $362.18 million.
Agilon Health Inc (AGL) Insider Activity
The most recent transaction is an insider purchase by Sell Steven, the company’s CEO & President. SEC filings show that Sell Steven bought 20,000 shares of the company’s common stock on Sep 12 ’24 at a price of $3.36 per share for a total of $67188.0. Following the purchase, the insider now owns 67590.0 shares.
Agilon Health Inc disclosed in a document filed with the SEC on Nov 29 ’23 that Schwaneke Jeffrey A. (Director) bought a total of 22,300 shares of the company’s common stock. The trade occurred on Nov 29 ’23 and was made at $11.22 per share for $0.25 million. Following the transaction, the insider now directly holds 31931.0 shares of the AGL stock.
